title: Mutant DNMT3A clone evading chemotherapy and infiltrating central nervous system in a patient with molecularly good-risk acute myeloid leukemia.
authors: Division of Hematology and Oncology, Chang Gung Memorial Hospital, Chiayi, Taiwan.
authors: Yi-Yang
authors: YY
authors: Chen
authors: Cih-En
authors: CE
authors: Huang
authors: Hui-Ju
authors: HJ
authors: Chou
authors: Pei-Shan
authors: PS
authors: Tsai
authors: Chang-Hsien
authors: CH
authors: Lu
authors: Miao-Fen
authors: MF
authors: Chen
authors: Kuan-Der
authors: KD
authors: Lee
authors: Ping-Tsung
authors: PT
authors: Chen
authors: Jrhau
authors: J
authors: Lung
authors: Chih-Cheng
authors: CC
authors: Chen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001921:Brain / Q000473:pathology*; D002999:Clone Cells / Q000187:drug effects; D003561:Cytarabine / Q000008:administration & dosage; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000235:genetics* / Q000502:physiology; D000090205:DNA Methyltransferase 3A; D004273:DNA, Neoplasm / Q000134:cerebrospinal fluid / Q000235:genetics; D003630:Daunorubicin / Q000008:administration & dosage; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000473:pathology; D017254:Leukemic Infiltration; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics* / Q000502:physiology; D014411:Neoplastic Stem Cells / Q000187:drug effects; D011379:Prognosis; D012306:Risk
chemical_list: D004273:DNA, Neoplasm; C000717967:DNMT3A protein, human; D009363:Neoplasm Proteins; D003561:Cytarabine; D004248:DNA (Cytosine-5-)-Methyltransferases; D000090205:DNA Methyltransferase 3A; D003630:Daunorubicin